Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Ethics Subcommittee (ES), 29755-29756 [2011-12562]

Download as PDF 29755 Federal Register / Vol. 76, No. 99 / Monday, May 23, 2011 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Number of responses per respondent Average burden per response Total burden hours CFR Form name 73.19(a)(b) ...................................... 180 1 1 180 320 9 1 2,880 73.5 & 73.6(d–e) ............................. 73.3 & 73.4(e)(1) ............................ 73.10(e) ........................................... 73.20 ............................................... 73.18 ............................................... Notification of Theft, Loss or Release. Report of Identification of Select Agent. Request of Exemption .................... Request for Exclusions/Restricted Request for Expedited Review ....... Administrative Review .................... Inspections ..................................... 3 71 1 30 320 1 1 1 1 1 1 1 1 4 8 3 71 1 120 2,560 Total ......................................... ......................................................... ........................ ........................ 73.5 & 73.6(a)(b) ............................ Dated: May 17, 2011. Daniel Holcomb, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–12571 Filed 5–20–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) srobinson on DSK4SPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned committee: Time and Date 8 a.m.–6 p.m., June 22, 2011. 8 a.m.–4 p.m., June 23, 2011. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters To Be Discussed: The agenda will include discussions on: human papillomavirus vaccines, pertussis, meningococcal vaccine, influenza, VerDate Mar<15>2010 16:22 May 20, 2011 Jkt 223001 febrile seizures related to vaccine administration, herpes zoster vaccine, 13-valent pneumococcal conjugate vaccine (PCV13), new MMR Vaccine Work Group, two dose varicella vaccination and hepatitis B vaccine. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Stephanie B. Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E–05), Atlanta, Georgia 30333, Telephone: (404)639–8836, Fax: (404)639–8905, E-mail: acip@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: May 16, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–12563 Filed 5–20–11; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Ethics Subcommittee (ES) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: TIMES AND DATES: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 ............................ 8,878 1 p.m.–5 p.m., June 16, 2011 8:30 a.m.–12:30 p.m., June 17, 2011 PLACE: CDC, Thomas R. Harkin Global Communications Center, Distance Learning Auditorium, 1600 Clifton Road, NE., Atlanta, Georgia 30333. This meeting is also available by teleconference. Please dial (877) 928– 1204 and enter code 4305992. STATUS: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment. The public comment periods are tentatively scheduled from 4 p.m.–4:15 p.m. on June 16, 2011 and from 12 p.m.–12:15 p.m. on June 17, 2011. PURPOSE: The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners. MATTER TO BE DISCUSSED: Agenda items will include the following: An update on ES presentation during the April 28, 2011, ACD, CDC meeting; discussion of next steps on addressing potential public health ethical issues associated with implementation of effective preventive interventions for noncommunicable disease; and review of workgroup progress on developing practical tools to assist state, tribal, local, and territorial health departments in their efforts to address public health ethics challenges. The agenda is subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: For security reasons, members of the public interested in attending the meeting should contact Drue Barrett, PhD, Designated Federal Officer, ACD, CDC–ES, 1600 Clifton Road, NE., M/S D–50, Atlanta, Georgia 30333. Telephone (404) 639–4690. E-mail: dbarrett@cdc.gov. The deadline for E:\FR\FM\23MYN1.SGM 23MYN1 29756 Federal Register / Vol. 76, No. 99 / Monday, May 23, 2011 / Notices notification of attendance is June 10, 2011. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 16, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–12562 Filed 5–20–11; 8:45 am] BILLING CODE 4163–18–P Dated: May 16, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [FR Doc. 2011–12561 Filed 5–20–11; 8:45 am] BILLING CODE 4163–18–P srobinson on DSK4SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review DEPARTMENT OF HEALTH AND HUMAN SERVICES The meeting announced below concerns Centers for Agricultural Disease and Injury Research, Education, and Prevention, Program Announcement (PA) Number PAR–11– 022, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: TIME AND DATE: 8 a.m.–6:30 p.m., June 6, 2011 (Closed) 8 a.m.–6:30 p.m., June 7, 2011 (Closed) 8 a.m.–6:30 p.m., June 8, 2011 (Closed) 8 a.m.–6:30 p.m., June 9, 2011 (Closed) 8 a.m.–6:30 p.m., June 10, 2011 (Closed) Place: Doubletree by Hilton Philadelphia Center City, 237 S. Broad Street, Philadelphia, Pennsylvania 19107. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Centers for Agricultural Disease and VerDate Mar<15>2010 16:22 May 20, 2011 Jkt 223001 Injury Research, Education, and Prevention, PAR–11–022, initial review.’’ Contact Person for More Information: M. Chris Langub, PhD, Scientific Review Officer, Office of Extramural Programs, 1600 Clifton Road, NE., Mailstop E74, Atlanta, Georgia 30333, Telephone: (404) 498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: TIMES AND DATES: 9 a.m.–5 p.m., June 16, 2011. 9 a.m.–12 p.m., June 17, 2011. PLACE: CDC, Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road, NE., Atlanta, Georgia, 30333. STATUS: Open to the public, limited only by the space available. Please register for the meeting at https://www.cdc.gov/ hicpac. PURPOSE: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and the Director, Division of Healthcare Quality Promotion regarding (1) The practice of healthcare infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 guidelines and other policy statements regarding prevention of healthcareassociated infections and healthcarerelated conditions. MATTERS TO BE DISCUSSED: The agenda will include updates on CDC’s activities for healthcare associated infections; draft guidelines for prevention of infections among patients in neonatal intensive care units (NICU); draft guidelines for infection control in healthcare personnel; draft guidelines for the prevention of surgical site infections; update from the HICPAC surveillance working group; and discussion of a draft infection control worksheet for acute-care hospitals. Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Heidi Williams, HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333, Telephone (404) 639–4227. Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 16, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–12560 Filed 5–20–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Office of Planning, Research and Evaluation; Advisory Committee on Head Start Research and Evaluation Administration for Children and Families, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: This notice announces a forthcoming meeting of a public advisory committee of the Administration for Children and Families (ACF). The meeting will be open to the public. Name of Committee: Advisory Committee for Head Start Research and Evaluation. SUMMARY: E:\FR\FM\23MYN1.SGM 23MYN1

Agencies

[Federal Register Volume 76, Number 99 (Monday, May 23, 2011)]
[Notices]
[Pages 29755-29756]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12562]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)--Ethics Subcommittee (ES)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:

Times and Dates: 
    1 p.m.-5 p.m., June 16, 2011
    8:30 a.m.-12:30 p.m., June 17, 2011

Place: CDC, Thomas R. Harkin Global Communications Center, Distance 
Learning Auditorium, 1600 Clifton Road, NE., Atlanta, Georgia 30333. 
This meeting is also available by teleconference. Please dial (877) 
928-1204 and enter code 4305992.

Status: Open to the public, limited only by the space available. The 
meeting room accommodates approximately 60 people. To accommodate 
public participation in the meeting, a conference telephone line will 
be available. The public is welcome to participate during the public 
comment. The public comment periods are tentatively scheduled from 4 
p.m.-4:15 p.m. on June 16, 2011 and from 12 p.m.-12:15 p.m. on June 17, 
2011.

Purpose: The ES will provide counsel to the ACD, CDC, regarding a broad 
range of public health ethics questions and issues arising from 
programs, scientists and practitioners.

Matter To Be Discussed: Agenda items will include the following: An 
update on ES presentation during the April 28, 2011, ACD, CDC meeting; 
discussion of next steps on addressing potential public health ethical 
issues associated with implementation of effective preventive 
interventions for noncommunicable disease; and review of workgroup 
progress on developing practical tools to assist state, tribal, local, 
and territorial health departments in their efforts to address public 
health ethics challenges. The agenda is subject to change as priorities 
dictate.

Contact Person for More Information:  For security reasons, members of 
the public interested in attending the meeting should contact Drue 
Barrett, PhD, Designated Federal Officer, ACD, CDC-ES, 1600 Clifton 
Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404) 639-4690. 
E-mail: dbarrett@cdc.gov. The deadline for

[[Page 29756]]

notification of attendance is June 10, 2011.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: May 16, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-12562 Filed 5-20-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.